PD 237 (Zarontin 250 mg)
Generic Name: ethosuximide
Pill with imprint PD 237 is Orange, Capsule-shape and has been identified as Zarontin 250 mg. It is supplied by Parke-Davis.
Zarontin is used in the treatment of seizures and belongs to the drug class succinimide anticonvulsants. FDA has not classified the drug for risk during pregnancy. Zarontin 250 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for PD 237
Zarontin
- Generic Name:
- ethosuximide
- Imprint:
- PD 237
- Strength:
- 250 mg
- Color:
- Orange
- Size:
- 8.00 mm
- Shape:
- Capsule-shape
- Availability:
- Prescription only
- Drug Class:
- Succinimide anticonvulsants
- Pregnancy Category:
- N - Not classified
- CSA Schedule:
- Not a controlled drug
- Labeler / Supplier:
- Parke-Davis
- Inactive Ingredients:
- polyethylene glycol 400
D&C Yellow No. 10
FD&C Red No. 3
gelatin
glycerin
sorbitol
Note: Inactive ingredients may vary.
Other Labelers / Repackagers:
| NDC Code | Labeler / Repackager |
|---|---|
| 59762-2250 | Greenstone LLC |
More about Zarontin (ethosuximide)
- Zarontin Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Drug Images
- Drug Interactions
- Support Group
- Pricing & Coupons
- En Español
- 6 Reviews
- Generic Availability
- Drug class: succinimide anticonvulsants
Consumer resources
- Zarontin
- Zarontin (Ethosuximide Capsules)
- Zarontin (Ethosuximide Solution)
- Zarontin (Advanced Reading)
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
